[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351588-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351588-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","understanding-the-evolving-role-of-early-palliative-care-in-myelodysplastic-syndromes-a-2026-narrative-review","Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review","","A 2026 narrative review examines how early palliative care should be integrated into management of myelodysplastic syndromes (MDS), a heterogeneous set of blood cancers with widely varying symptom burden and quality-of-life impact. It highlights early symptom control, goal-directed advanced care planning, reduced reliance on aggressive therapies and intensive care, and more efficient end-of-life resource use. The review also links combined standard hematologic assessment with early palliative support to fewer late EOL visits and hospital admissions, with many patients dying at home or in hospice aligned to preferences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/understanding-the-evolving-role-of-early-palliative-care-in-myelodysplastic-syndromes-a-2026-narrative-review/351588/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/understanding-the-evolving-role-of-early-palliative-care-in-myelodysplastic-syndromes-a-2026-narrative-review/351588.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",24,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early palliative care considered important in myelodysplastic syndromes (MDS)?","Question",{"text":63,"@type":64},"Because MDS produces a heterogeneous symptom burden that affects quality of life, and early palliative care can improve symptom control and communication while supporting advanced care planning.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which end-of-life issues are addressed by integrating early palliative care in MDS management?",{"text":68,"@type":64},"The review emphasizes issues such as reducing aggressive therapies and intensive care use, optimizing resource use during the end-of-life phase, and enabling more patients to die at home or in hospice according to preferences.",{"name":70,"@type":61,"acceptedAnswer":71},"How does early palliative care relate to healthcare utilization near the end of life?",{"text":72,"@type":64},"Integrating early palliative care with standard hematological measures is reported to reduce late end-of-life visits and hospital admissions, particularly during the last 30 days.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351588,1790193815,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Annals of Hematology (2026) 105:286  \n[https://doi.org/10.1007/s00277-026-07042-9](https://doi.org/10.1007/s00277-026-07042-9)  \nREVIEW  \nUnderstanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review  \nPasquale Niscola1 · Valentina Gianfelici1 · Marco Giovannini1 · Carla Mazzone1 · Maria Ilaria Del Principe1,2  \nReceived: 31 January 2026 / Accepted: 24 April 2026 / Published online: 4 May 2026 © The Author(s) 2026  \nAbstract  \nContext/Objective. Myelodysplastic Syndromes/Neoplasms (MDS) are a heterogeneous group of blood cancers characterized by a broad spectrum of symptoms and varying impacts on quality of life (QoL) . Although the integration of early PC care has long been recognized as an essential part of comprehensive management for patients with solid tumors, experience in the context of MDS is still limited. However, symptom control, QoL, advanced care planning goals, the reduction of aggressive therapies, intensive care use, including intubation before death, and resource use in the end-of-life (EOL) phase are critical issues that are enhanced through early PC in MDS management. Additionally, integrating standard hematological measures with early PC leads to fewer visits and hospital admissions near the EOL, particularly during the last 30 days. Moreover, patients with early PC die at home or in hospice care at a rate nearly in line with their preferences. Therefore, routine early PC is a critical issue for patients with MDS, regardless of disease risk, as it improves patient outcomes, enhances communication, refines resource use, and reduces unnecessary aggressive procedures.  \nKeywords Early palliative care · Care at the end of life · Hospice care · Myelodysplastic syndromes · Quality of life · Symptoms management · Transfusion support  \nIntroduction: brief general overview of MDS  \nManaging myelodysplastic syndromes (MDS) is still a major challenge in modern hematology [1] . This diverse group of blood-related disorders includes heterogeneous myeloid neoplasms characterized by one or more peripheral cytopenias due to ineffective hematopoiesis, with a variable risk of progressing to acute myeloid leukemia (AML) [1– 4]. MDS is a disease that typically affects older adults, who may often suffer from concomitant comorbid conditions or are at high risk of developing them [5, 6] . The pathogenesis of MDS is multifactorial, arising from a complex interplay between intrinsic genetic abnormalities in hematopoietic stem cells and their malignant environment [3, 5] . Recent  \n􀀍 Pasquale Niscola[pniscola@gmail.com](pniscola@gmail.com)  \n1 Hematology Unit, Medical Area Department, S. Eugenio Hospital (ASL Roma 2), Piazzale dell’Umanesimo 10,, Rome 00144, Italy  \n2 Hematology, Department of Biomedicine and Prevention, University Tor Vergata ofRome, Rome 00133, Italy  \nadvances in the pathophysiological understanding of MDSand in genomic techniques have enabled the detection of molecular features, leading to novel diagnostic and prognostic capabilities and new targeted therapeutic approaches [1, 3, 7–11] . In line with these advances, new classification systems have been developed (Table 1) [12, 13] . Notably, genomic advances in research on the “transition” period from “MDS syndrome” to “specific pathologies” amenable to targeted therapy highlight the growing importance of molecular data over blast count in such a setting [8, 9, 11] .  \nEarly palliative care (PC) in the context of the symptom burden of MDS  \nFrom a clinical point of view, MDS are diseases that are heterogeneous and cause health deterioration or a lifethreatening clinical course and severe medical complications. In this regard, affected patients face disease-related concerns, particularly physical and mental challenges, as well as uncertainty about AML evolution [4, 5, 14] . Significantly, MDS presents a complex shared experience for affected individuals and their caregivers, who are engaged in affectionate and empa","cbCaiqfBJSGVwAVF","https://ap.wps.com/l/cbCaiqfBJSGVwAVF","pdf",1173203,16,"English","# Abstract\n# Introduction: brief general overview of MDS\n# Early palliative care in the context of the symptom burden of MDS\n## Table 1 Comparison of WHO 5th edition and ICC 2022 classifications\n## Table 2 Key aspects of symptom burden in MDS needing early palliative care","[{\"question\":\"Why is early palliative care considered important in myelodysplastic syndromes (MDS)?\",\"answer\":\"Because MDS produces a heterogeneous symptom burden that affects quality of life, and early palliative care can improve symptom control and communication while supporting advanced care planning.\"},{\"question\":\"Which end-of-life issues are addressed by integrating early palliative care in MDS management?\",\"answer\":\"The review emphasizes issues such as reducing aggressive therapies and intensive care use, optimizing resource use during the end-of-life phase, and enabling more patients to die at home or in hospice according to preferences.\"},{\"question\":\"How does early palliative care relate to healthcare utilization near the end of life?\",\"answer\":\"Integrating early palliative care with standard hematological measures is reported to reduce late end-of-life visits and hospital admissions, particularly during the last 30 days.\"}]","Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review | PDF",1790094852,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a964f061ce716a0f31cd22985093cfe.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4ed28f46e4b0a1b77f290a3ef5495f3.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1c6f104abaf2e42f67c6a7081ee96c5.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dbd78b800bd8881cfbbe0b396cfb02f.webp",980,1301]